Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy.

MLA

Hernández-Romero, D., et al. “Involvement of the -420C>G RETN Polymorphism in Myocardial Fibrosis in Patients with Hypertrophic Cardiomyopathy.” Journal of Internal Medicine, vol. 278, no. 1, July 2015, pp. 50–58. EBSCOhost, https://doi.org/10.1111/joim.12334.

APA

Hernández-Romero, D., Orenes-Piñero, E., García-Honrubia, A., Climent, V., Romero-Aniorte, A. I., Martínez, C. M., García-Bautista, M., Martínez, M., Feliu, E., González, J., Cánovas, S., Montero-Argudo, J. A., Valdés, M., & Marín, F. (2015). Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy. Journal of Internal Medicine, 278(1), 50–58. https://doi.org/10.1111/joim.12334

Chicago

Hernández-Romero, D, E Orenes-Piñero, A García-Honrubia, V Climent, A I Romero-Aniorte, C M Martínez, M García-Bautista, et al. 2015. “Involvement of the -420C>G RETN Polymorphism in Myocardial Fibrosis in Patients with Hypertrophic Cardiomyopathy.” Journal of Internal Medicine 278 (1): 50–58. doi:10.1111/joim.12334.